Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sobsey CA"'
Autor:
Sobsey CA; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, Canada., Froehlich BC; University of Victoria-Genome British Columbia Proteomics Centre, University of Victoria, Victoria, BC, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada., Mitsa G; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, Canada., Ibrahim S; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, Canada., Popp R; MRM Proteomics Inc., Montreal, QC, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.; Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, Canada.; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada.; CancerCare Manitoba Research Institute, Winnipeg, MB, Canada., de Bruin EC; Oncology R&D, AstraZeneca, Cambridge, United Kingdom., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Division of Experimental Medicine, McGill University, Montreal, QC, Canada.; Gerald Bronfman Department of Oncology, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC, Canada.; Department of Pathology, McGill University, Montreal, QC, Canada., Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada.; McGill Centre for Translational Research in Cancer, Lady Davis Institute, Montreal, QC, Canada.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Aug 01; Vol. 4 (8), pp. 2058-2074.
Autor:
Froehlich BC; University of Victoria - Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia V8Z 7X8, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8P 5C2, Canada., Popp R; University of Victoria - Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia V8Z 7X8, Canada., Sobsey CA; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Ibrahim S; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., LeBlanc A; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Mohammed Y; University of Victoria - Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia V8Z 7X8, Canada.; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia., Buchanan M; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Aguilar-Mahecha A; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Pötz O; NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen 72770, Germany.; SIGNATOPE GmbH, Reutlingen 72770, Germany., Chen MX; Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada., Spatz A; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Basik M; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Batist G; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A3T2, Canada. christoph.borchers@mcgill.ca., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia., Borchers CH; University of Victoria - Genome BC Proteomics Centre, University of Victoria, Victoria, British Columbia V8Z 7X8, Canada.; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8P 5C2, Canada.; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.; Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology, Moscow 121205, Russia.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A3T2, Canada. christoph.borchers@mcgill.ca.
Publikováno v:
The Analyst [Analyst] 2021 Oct 25; Vol. 146 (21), pp. 6566-6575. Date of Electronic Publication: 2021 Oct 25.